Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Clarium Health

Request full access

Using ai to help healthcare facilities predict demand, avoid shortages, and identify signals from noise in their data

New York City, United StatesFounded 2020Health Tech & Medtech

About Clarium Health

Clarium Health operates as a specialized technology firm targeting inefficiencies within the U.S. healthcare supply chain, a market sector losing over $25 billion annually to operational waste. The company was established in New York in 2020 by Steve Liou, who serves as CEO. Liou's background as a healthcare investor for over a decade at firms like Point72 and Citadel provided him with deep insights into the systemic vulnerabilities of hospital supply chains, a problem acutely highlighted during the COVID-19 pandemic. This experience directly informed the creation of Clarium.

The company's business model is centered on selling its AI-powered SaaS platform, Astra OS, directly to hospital systems. This platform functions as an end-to-end operating system for supply chain management, designed to unify fragmented data from a hospital's existing enterprise resource planning (ERP), electronic health record (EHR), and other legacy IT systems without requiring modifications. Astra OS collects, cleans, and standardizes this data in real-time, integrating it with external feeds from suppliers and vendors, as well as contextual data on weather and geopolitical events. By creating a unified data ecosystem, the platform provides predictive insights to anticipate potential supply disruptions and automate workflows.

Key applications built on Astra OS include Disruption Monitor, which provides a control tower for resolving supply issues; Substitute Manager, for identifying and approving clinically equivalent products from a proprietary database; and Card Optimizer, which uses AI to streamline and standardize supplies for surgical procedures. For its clients, which include major health systems like Yale New Haven Health, Stanford, Kaiser Permanente, and The Cleveland Clinic, Clarium has demonstrated significant return on investment. Reported outcomes for partners include average cost savings of over $10 million, a 50% faster resolution time for supply disruptions, and up to an 88% substitute approval rate. The company has raised a total of $43 million in capital, including a $27 million Series A round in May 2025 led by Northzone, with participation from General Catalyst, AlleyCorp, and several health system venture arms.

Source: Dealroom company data

At a glance

Status
Operational
Employees
60
Open positions
4
Dealroom signal
58.7/100
Industry
Health
Sub-industry
Health Platform
Sector
Core AI, Hard Tech, AI Applications
Technology
Artificial Intelligence
Business model
SaaS
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC May 2025 $27M $108M AlleyCorp · General Catalyst · 1984 Ventures · TMC Venture Fund ↗
EARLY VC✓Equity / VC Aug 2024 $11M $42M General Catalyst · Kaiser Permanente Ventures · 1984 Ventures · Alumni Ventures ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Clarium Health website traffic

Latest recorded traffic for Clarium Health is 4.6K monthly website visits, down 2.1% over the last three months. Clarium Health's team grew 9.1% over the past year.

Latest monthly visits4.6K 3-month web change-2.1% 1-year team growth+9.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Clarium Health in the New York City ecosystem

Live from Dealroom

The Clarium Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed6 investors entered at this stage

  • Liquid 2 Ventures
  • Hyphen Capital
  • 1984 Ventures
  • Labor Capital
  • AlleyCorp
  • Refashiond

Series A6 investors entered at this stage

Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States98.2%
🇨🇦 Canada1.8%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Clarium Health on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Clarium Health’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.